SEC Filing Summary: National Health Investors, Inc. (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors, Inc. on November 6, 2025. The filing serves as a Regulation FD disclosure to disseminate an investor presentation and a corresponding press release titled "NHI Issues Investor Update." The company is a Maryland corporation with its principal executive offices in Murfreesboro, TN, and its common stock trades on the New York Stock Exchange under the symbol NHI.
Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a conduit for external materials (Exhibits 99.1 and 99.2) rather than containing the financial data directly within the 8-K body.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The report solely announces the release of an investor update and presentation.
Guidance, Outlook, and Risks
Management commentary, guidance, and outlook are contained within the attached investor presentation and press release (Exhibits 99.1 and 99.2). The filing explicitly states that the information in these exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the specific financial metrics and operational updates by reviewing Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation) on the company website (www.nhireit.com).
- Note that the content of the investor update is not legally "filed" with the SEC under Section 18 of the Exchange Act, limiting liability protections for the information contained therein.
- Confirm the date of the update is November 6, 2025, as signed by John L. Spaid, Principal Financial Officer.